DCM
VSTM icon

DAFNA Capital Management’s Verastem VSTM Stock Holding History

DAFNA Capital Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-127,700
Closed -$382K – 88
2024
Q3 		$382K Buy
+127,700
New +$346K 0.09% 74

Other funds holding VSTM

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DAFNA Capital Management's VSTM Position: Q4 2024 in Review

DAFNA Capital Management sold out of Verastem (VSTM) in Q4 2024, closing a stake of 127,700 shares — an estimated $382K sold.

DAFNA Capital Management first reported a position in VSTM in Q3 2024 and held it in 1 quarter. The position peaked at $382K in Q3 2024. 92 funds tracked by Wall St. Rank hold VSTM as of Q4 2024.

  • DAFNA Capital Management reported no remaining Verastem position as of Q4 2024 after selling out during the quarter.
  • DAFNA Capital Management sold 127,700 Verastem shares in Q4 2024, an estimated $382K.
  • DAFNA Capital Management first reported a position in Verastem in Q3 2024 and held it in 1 quarter.
  • DAFNA Capital Management's Verastem position peaked at $382K in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Verastem as of Q4 2024.

Based on DAFNA Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.